arrow
R

Richard Canters

maastricht university medical centre+
H指数:23
被引数:2,122

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Improved organs-of-interest dose reduction potential with intensity modulated proton therapy and breath-hold in mediastinal lymphoma

通过调强质子治疗和屏气技术改善纵隔淋巴瘤感兴趣器官的剂量降低潜力

2026-05-100
OAAI
Prediction of pneumonia following neoadjuvant chemoradiotherapy in patients with oesophageal cancer

预测接受新辅助放化疗的食管癌患者术后肺炎的发生

2026-05-020
OAAI
Multicentre dosimetry audit in the European randomized phase III study of neoadjuvant chemoradiotherapy using proton versus photon radiotherapy in locally advanced oesophageal cancer

多中心剂量学核查:欧洲随机III期研究,比较局部晚期食管癌新辅助化疗联合质子放射治疗与光子放射治疗的应用

2026-02-280
OAAI
Effects of anatomical changes on dose and normal tissue complication probabilities and the benefit of replanning in photon and proton therapy of lung cancer patients

解剖结构变化对剂量和正常组织并发症概率的影响以及在肺癌患者的光子与质子治疗中重规划的好处

2025-07-260
PRE
Radiotherapy quality assurance in the PROTECT trial - a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer

PROTECT试验中的放射治疗质量保证——一项比较质子与光子疗法治疗食管癌患者的欧洲随机III期试验

2025-03-130
OA
Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy

III期NSCLC的质子和光子放疗: 对血液学毒性和辅助免疫治疗的影响

2024-01-0110
OAAI
Proton versus photon therapy for esophageal cancer - A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer
2024-01-014
OAAI